Reta Pen 20mg – Retatrutide Research Pen

Reta Pen 20mg is a contained Retatrutide research product supplied by Reverb Peptides for qualified laboratories, researchers and scientific organisations in the UK.

The product contains Retatrutide as the named research compound and provides a total listed amount of 20mg within a clearly identified pen-style presentation. It is the smaller of the two confirmed contained Reta formats available from Reverb Peptides and may suit laboratories that require a defined quantity for a controlled research programme.

Retatrutide is an investigational compound associated with GLP-1, GIP and glucagon receptor pathways. Its three-pathway profile places it within the triple-agonist research category and makes it relevant to controlled scientific investigation involving receptor signalling, pathway comparison, analytical characterisation and related laboratory research questions.

Reta Pen 20mg is supplied strictly for laboratory and scientific research purposes only. It is not a medicine, supplement or approved medical device. It is not intended for human consumption, veterinary use, self-administration, injection, treatment, diagnosis, prevention, weight management or any other personal application.

Reta Pen 20mg Product Overview

Reta is the catalogue name used by Reverb Peptides for its Retatrutide research range.

The confirmed Reta range currently includes